Ethaselen Uses, Dosage, Side Effects and more
Ethaselen is under investigation in clinical trial NCT02166242 (Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers).
| Trade Name | Ethaselen |
| Generic | Ethaselen |
| Type | |
| Formula | C16H12N2O2Se2 |
| Weight | Average: 422.226 Monoisotopic: 423.922922 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
